Is Trazodone Addictive? Medical Facts, Dependency Risks, and Side Effects
By Alexander Ross
Trazodone behaves like two distinct drugs depending on the dose swallowed before bedtime. The table below outlines how escalating dosage shifts the primary target, clinical indication, and discontinuation risks:
| Clinical Purpose | Dosage Range | Primary Pharmacological Target | Physiological Adaptation Risk |
|---|---|---|---|
| Insomnia Management(Off-Label) | 25 mg, 100 mg nightly | Potent 5-HT2A blockade, H1 histamine, and alpha-1 adrenergic antagonism | Moderate: Severe rebound insomnia upon abrupt cessation |
| Anxiety Relief Adjunct(Off-Label) | 50 mg, 150 mg divided | Balanced 5-HT2A/5-HT2C inhibition, partial serotonin transport modulation | Moderate-to-High: Anxiety spikes, autonomic instability on sudden stop |
| Major Depressive Disorder(FDA-Approved) | 150 mg, 400 mg daily | Serotonin reuptake inhibition (SERT) combined with 5-HT2A antagonism | High: Full-scale antidepressant discontinuation syndrome |
At low levels, trazodone does not saturate the serotonin transporter (SERT) protein. It simply dims alert signals in the brainstem. Once doses cross the 150 mg threshold, SERT inhibition kicks into gear, functioning as a true psychoactive mood stabilizer. Because sleep medicine relies almost exclusively on the sub-100 mg range, patients rarely gain therapeutic mood improvements from low-dose sleep prescriptions alone, despite taking a drug cataloged as an antidepressant.
Alexander Ross has covered the video game industry for a decade, writing deep dives on game design, esports tournaments, VR developments, and gaming culture.
